Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Homology Medicines, Inc. (NASDAQ: FIXX).

Full DD Report for FIXX

You must become a subscriber to view this report.


Recent News from (NASDAQ: FIXX)

Homology Medicines misses by $0.43, beats on revenue
Homology Medicines (NASDAQ: FIXX ): Q1 EPS of -$4.21 misses by $0.43 . Revenue of $0.82M beats by $0.29M . Press Release More news on: Homology Medicines, Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: May, 14 2018 16:46
Homology Medicines Reports First Quarter 2018 Financial Results
BEDFORD, Mass. , May 14, 2018 /PRNewswire/ -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the quarter ended March 31, 2018 , and highlighted recent accomplishments. "Completing our initial public offering this ...
Source: PR Newswire
Date: May, 14 2018 16:25
Genomic Medicine: Catch The Gene Therapy Wave
Genomic medicine is the future of healthcare. Spawned by the Human Genome Project “HGP” this precise and personal approach to medicine is an emerging discipline with enormous disruptive potential. Though nascent, Genomic medicine is showing signs of being the transformative for...
Source: SeekingAlpha
Date: May, 14 2018 15:12
Homology Medicines to Present at Bank of America Merrill Lynch Healthcare Conference
BEDFORD, Mass. , May 10, 2018 /PRNewswire/ -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management will present at the Bank of America Merrill Lynch 2018 Healthcare Conference on May 15, 2018 at 10:40 a.m. PT in Las Vegas ...
Source: PR Newswire
Date: May, 10 2018 08:30
Pushing Preclinical: Wave Of Early-Stage Biotech IPOs Tests Investor Risk Appetite
Biotechs are among the most risky of IPOs due to the binary nature of the success… or failure of their drugs. In the past, most biotechs delayed public offerings until they at least showed clinical evidence of their safety or efficacy. But in 2018, biotechs are increasingly going publ...
Source: SeekingAlpha
Date: May, 09 2018 05:37
Homology Medicines Announces Upcoming Presentations on its Genetic Medicines Platform at the American Society of Gene & Cell Therapy Meeting
BEDFORD, Mass. , April 30, 2018 /PRNewswire/ -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that data from its gene editing and gene therapy platform, including data from its phenylketonuria (PKU) programs, will be presented during the ...
Source: PR Newswire
Date: April, 30 2018 12:41
Premarket analyst action - healthcare
Homology Medicines (NASDAQ: FIXX ) initiated with Buy rating and $27 (32% upside) price target at BofAMerrill Lynch. Initiated with Outperform rating at Cowen and Company. Shares up  3%  premarket. More news on: Homology Medicines, Knight Therapeutics Inc, Unum Therapeutics Inc.,...
Source: SeekingAlpha
Date: April, 23 2018 09:04
Homology Medicines to Participate in the World Orphan Drug Congress
BEDFORD, Mass. , April 23, 2018 /PRNewswire/ -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management is scheduled to participate in the World Orphan Drug Congress USA 2018 at the Gaylord National Harbor Hotel in Oxon Hill, M...
Source: PR Newswire
Date: April, 23 2018 09:00
Stocks To Watch: Earnings Blockbusters And Trump Talks Drug Prices
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Earnings for companies listed in the S&P 500 Index are up 26% from a year ago f...
Source: SeekingAlpha
Date: April, 21 2018 09:30
Can Homology Sustain Success?
The biotech IPO market is at its strongest point in some time, and Homology Medicines Inc. (FIXX) has taken advantage to run a successful IPO. According to Xconomy , Homology raised $144 million Tuesday evening by selling 9 million shares at $16 apiece. Homology shares were released to the pu...
Source: SeekingAlpha
Date: April, 11 2018 14:47

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1719.4919.3520.113519.0671,922

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-149,11439,48723.0810Cover
2018-08-1311,22254,37220.6393Cover
2018-08-1015,22922,51067.6544Short
2018-08-092,9178,47434.4229Cover
2018-08-084,9868,37659.5272Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on FIXX.


About Homology Medicines, Inc. (NASDAQ: FIXX)

Logo for Homology Medicines, Inc. (NASDAQ: FIXX)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: FIXX)

      Amendment to a previously filed Form 4
      Filing Type: 4/AFiling Source: edgar
      Filing Date: May, 16 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 14 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: April, 11 2018
      Filing by person(s) reporting owned shares of common stock in a public company >5%
      Filing Type: SC 13DFiling Source: edgar
      Filing Date: April, 06 2018
      Amendment to a previously filed Form 4
      Filing Type: 4/AFiling Source: edgar
      Filing Date: April, 04 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 03 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: March, 30 2018
      Prospectus filed under Rule 424(b)(4)
      Filing Type: 424B4Filing Source: edgar
      Filing Date: March, 29 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: March, 29 2018
      Amendment to general form for registration of securities under the Securities Act of 1933
      Filing Type: S-1/AFiling Source: edgar
      Filing Date: March, 27 2018

       

       


      Daily Technical Chart for (NASDAQ: FIXX)

      Daily Technical Chart for (NASDAQ: FIXX)


      Stay tuned for daily updates and more on (NASDAQ: FIXX)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: FIXX)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in FIXX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of FIXX and does not buy, sell, or trade any shares of FIXX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/